$16.3 Billion is the total value of Point72 Asset Management, L.P.'s 1088 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UTX | UNITED TECHNOLOGIES CORPcall | $27,304,000 | +4.9% | 200,000 | 0.0% | 0.17% | +23.5% | |
| PFE | PFIZER INCput | $10,779,000 | -17.1% | 300,000 | 0.0% | 0.07% | -2.9% | |
| XENE | XENON PHARMACEUTICALS INC | $8,334,000 | -8.6% | 925,000 | 0.0% | 0.05% | +6.2% | |
| WY | WEYERHAEUSER COcall | $8,310,000 | +5.2% | 300,000 | 0.0% | 0.05% | +24.4% | |
| APTOSE BIOSCIENCES INC | $4,587,000 | -20.1% | 2,200,000 | 0.0% | 0.03% | -6.7% | ||
| WWE | WORLD WRESTLING ENTMT INCcall | $3,558,000 | -1.5% | 50,000 | 0.0% | 0.02% | +15.8% | |
| MTEM | MOLECULAR TEMPLATES INC | $1,328,000 | -21.0% | 201,495 | 0.0% | 0.01% | -11.1% | |
| MLND | MILLENDO THERAPEUTICS INC | $538,000 | -38.5% | 75,670 | 0.0% | 0.00% | -40.0% | |
| GREK | GLOBAL X FDSmsci greece etf | $280,000 | -2.4% | 30,000 | 0.0% | 0.00% | 0.0% | |
| EPHE | ISHARES TRmsci philips etf | $335,000 | -5.9% | 10,000 | 0.0% | 0.00% | 0.0% | |
| WTI | W & T OFFSHORE INC | $95,000 | -12.0% | 21,787 | 0.0% | 0.00% | 0.0% | |
| PRFT | PERFICIENT INC | $114,000 | +12.9% | 2,943 | 0.0% | 0.00% | 0.0% | |
| ONTX | ONCONOVA THERAPEUTICS INC | $205,000 | -70.2% | 241,850 | 0.0% | 0.00% | -75.0% | |
| MGEN | MIRAGEN THERAPEUTICS INC | $73,000 | -64.2% | 99,691 | 0.0% | 0.00% | -100.0% | |
| KAMN | KAMAN CORP | $48,000 | -5.9% | 800 | 0.0% | 0.00% | – | |
| IPAR | INTER PARFUMS INC | $14,000 | +7.7% | 200 | 0.0% | 0.00% | – | |
| INDB | INDEPENDENT BANK CORP MASS | $37,000 | -2.6% | 500 | 0.0% | 0.00% | – | |
| FSS | FEDERAL SIGNAL CORP | $49,000 | +22.5% | 1,500 | 0.0% | 0.00% | – | |
| CRS | CARPENTER TECHNOLOGY CORP | $31,000 | +6.9% | 600 | 0.0% | 0.00% | – | |
| BANR | BANNER CORP | $6,000 | +20.0% | 100 | 0.0% | 0.00% | – | |
| AIN | ALBANY INTL CORPcl a | $18,000 | +5.9% | 200 | 0.0% | 0.00% | – | |
| SJI | SOUTH JERSEY INDS INC | $10,000 | 0.0% | 300 | 0.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TR | 38 | Q3 2023 | 8.2% |
| CME GROUP INC | 38 | Q3 2023 | 0.3% |
| BUNGE LIMITED | 37 | Q2 2023 | 1.5% |
| AMAZON COM INC | 36 | Q3 2023 | 3.2% |
| META PLATFORMS INC | 36 | Q3 2023 | 2.2% |
| VISA INC | 35 | Q3 2023 | 1.6% |
| AIR PRODS & CHEMS INC | 35 | Q3 2023 | 0.7% |
| BERRY PLASTICS GROUP INC | 35 | Q3 2023 | 0.8% |
| XENON PHARMACEUTICALS INC | 35 | Q3 2023 | 0.4% |
| CSX CORP | 34 | Q3 2023 | 1.3% |
View Point72 Asset Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Turnstone Biologics Corp. | July 27, 2023 | 833,333 | 3.8% |
| Praxis Precision Medicines, Inc. | June 26, 2023 | 10,438,522 | 8.1% |
| Cepton, Inc. | March 09, 2023 | 1,813,535 | 1.2% |
| Achilles Therapeutics plc | February 14, 2023 | 1,413,809 | 3.6% |
| Affimed N.V. | February 14, 2023 | 4,207,220 | 2.8% |
| Akero Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Applied Therapeutics Inc. | February 14, 2023 | 719,938 | 3.2% |
| Atara Biotherapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Avalo Therapeutics, Inc. | February 14, 2023 | 500,737 | 5.3% |
| Axogen, Inc. | February 14, 2023 | 1,815,000 | 4.3% |
View Point72 Asset Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-05-21 |
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-05-09 |
| SC 13G | 2024-04-26 |
| SC 13G | 2024-04-05 |
| SC 13G | 2024-03-26 |
| SC 13G | 2024-03-25 |
| SC 13G | 2024-03-07 |
| SC 13G | 2024-02-29 |
| SC 13G | 2024-02-27 |
View Point72 Asset Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.